Biocon Limited has informed the Exchange regarding a press release dated August 07, 2025, titled "Biocon Q1FY26 Operating Revenue at Rs 3,942 Cr, Up 15%EBITDA at Rs 829 Cr; Up 19%*;PBT (before exceptional item) at Rs 97 Cr, Up 72%*Biosimilars Up 18%, CRDMO Up 11% and Generics Up 6%".